A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.
Saved in:
| Title: | A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256. |
|---|---|
| Authors: | Wilkin TJ (AUTHOR), Lalama CM (AUTHOR), McKinnon J (AUTHOR), Gandhi RT (AUTHOR), Lin N (AUTHOR), Landay A (AUTHOR), Ribaudo H (AUTHOR), Fox L (AUTHOR), Currier JS (AUTHOR), Mellors JW (AUTHOR), Gulick R (AUTHOR), Tenorio AR (AUTHOR), Wilkin, Timothy J1 (AUTHOR), Lalama, Christina M (AUTHOR), McKinnon, John (AUTHOR), Gandhi, Rajesh T (AUTHOR), Lin, Nina (AUTHOR), Landay, Alan (AUTHOR), Ribaudo, Heather (AUTHOR), Fox, Lawrence (AUTHOR) |
| Source: | Journal of Infectious Diseases. 8/15/2012, Vol. 206 Issue 4, p534-542. 9p. |
| Database: | Environment Complete |
| ISSN: | 00221899 |
|---|---|
| DOI: | 10.1093/infdis/jis376 |
